Today on DrugResearcher.com
 
AstraZeneca in 'serious trouble', say analysts

Giving lung cancer a Smac

Nanogen scraps microarray business in favour of PCR assays

Applied Biosystems and BioTrove form HT genotyping alliance

New drug safety model unveiled as Merck shells out for Vioxx

 
   
Related Industry News
 
NPIL to trim ex-Pfizer site

PharmEng opens new Canada plant

Practice run for pharma RFID

China gets serious on drug GMP; safety pact with FDA imminent

 
 

Drug discovery

Breaking News on Drug Discovery
Daily  Tuesday 13 November 2007 Forward to a colleague

Product Presentation

SequantZIC®-HILIC Separation of Polar and Hydrophilic Compounds

The technology leading ZIC®HILIC and ZIC®-pHILIC separation media, designed for polar and hydrophilic compounds, are tools for clinical analysis and to solve separation and purification problems in research, development and production of pharmaceuticals. ZIC®-HILIC... Click Here

Access Full Stories



AstraZeneca in 'serious trouble', say analysts
An analyst report released yesterday identified AstraZeneca as being in 'serious trouble' and branded it as potentially the 'worst [large cap] performer in [the] entire sector' over the next eight years... Read


Giving lung cancer a Smac
A small molecule version of a protein called Smac can turn the survival signal for a variety of tumour cells into a death signal and could be effective as a new class of drug, especially for lung cancer patients... Read


Nanogen scraps microarray business in favour of PCR assays
Nanogen has decided to pull the plug on its microarray business after not finding any 'financially meaningful opportunities' for it, reducing staff by 20 per cent in the process... Read


Applied Biosystems and BioTrove form HT genotyping alliance
Applied Biosystems and BioTrove have signed a licensing and collaboration agreement to commercialise an analysis platform for high-throughput (HT) genotyping applications... Read


New drug safety model unveiled as Merck shells out for Vioxx
A new 3D model of the human liver that even has its own blood supply could pump new life into drug safety tests by predicting problems earlier and cut down on animal experiments... Read


All News Headlines for:
November | October | September

Fully autoclavable and Universal tip fittingSponsored Link

CappAero pipettes - ultimate accuracy and intelligent design

The cool transparent handle and dash of vibrant colour on the barrel ensures the ColorLine series will be a welcome addition to any laboratory. The distinctive colour of each pipette permits you to quickly identify the volume range of any pipette at a glance... Click Here

Related Industry News



NPIL to trim ex-Pfizer site
NPIL Pharma last week told workers at its former Pfizer plant in Morpeth, UK that the company is considering hiving off jobs in a bid to maintain the site's viability... Read


PharmEng opens new Canada plant
Canadian contract manufacturer PharmEng recently announced that its new specialised manufacturing facility in Nova Scotia is open for business... Read


Practice run for pharma RFID
IBM has teamed up with RFID specialist Tagsys to offer pharmaceutical manufacturers a chance to have a practice run implementing their RFID track and trace technology ahead of new legal requirements coming into... Read


China gets serious on drug GMP; safety pact with FDA imminent
As of next year Chinese pharmaceutical manufacturers will face a tougher time gaining good manufacturing practice (GMP) certification after the country's regulator signalled new and stricter standards were on the... Read


Weekly Comment

Pharma must 'reinvent' itself to survive

With IMS Health's annual forecast for the pharma industry predicting slower approvals, more black box warnings and the continuation of the 'wave of genericization,' the shift by pharma firms to refocus and reinvent themselves will need to move on apace in order to secure their position in a changing market. Read



SMI Anti-Arthritic ConferenceSponsored Link

7th Annual Anti-Arthritic Agents Conference

Examine the latest developments in the research of therapeutics for Arthritic and Inflammatory indications, and listen to case studies from the leading companies in the field. 19th & 20th November 2007, Hesperia Victoria Hotel, UK... Click Here
Previous Headlines



WHO talks on research strategy for developing world diseases stall
Talks between World Health Organization (WHO) member states and the drug industry over how to narrow the health gap between rich and poor countries have stalled... Read


BAC looks to enhance laboratory purification with new antibody toolkit
Bio Affinity Company (BAC) has launched a new antibody purification toolbox based on its successful industrial-scale technology to provide researchers with a simpler purification route... Read


Tripos lands Schering-Plough deal
Tripos Discovery Research (TDR) has risen from the ashes surrounding the liquidation of its previous owners Tripos, Inc. to land a 'library enrichment' deal with Schering-Plough... Read


China CRO attracts $30m US investment
China's second largest contract research organisation (CRO) ShangPharma has attracted $30m (€21m) from US private investment firm TPG as the Asian pharma market continues to simmer... Read


Aveo strategy ups chances of cancer drug success
US-based Aveo Biopharmaceuticals is hoping to prove its R&D strategy can buck high industry failure rates when trying to design new cancer drugs and it seems to be working after its lead drug has passed a first-in-man... Read

Technical / White Papers, Case studies, Web casts
Benefits of integrating human tissue research in drug discovery - Technical / White Paper

Manufacturing Variations in Polysorbate Batches - Technical / White Paper



Product Information - brochures, Web centers
ZIC®-HILIC Separation of Polar and Hydrophilic Compounds - Product Presentation

DAICEL chiral chromatography products - Company Profile

Rapid HPLC method development with ChromSword®Auto software - Product Presentation

Separation of polar compounds - Application Notes



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com